ArticleCurrent medicinal chemistry2025
MEF2C is a Potential Prognostic Biomarker and is Correlated with Immune Infiltrates in Lung Adenocarcinoma.
Ke Liang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it